Turn Therapeutics CFO Zuraiz buys 2500 shares at $3.5/share on 2025-12-12.

viernes, 12 de diciembre de 2025, 6:07 pm ET1 min de lectura
TTRX--

Turn Therapeutics Inc. (TTRX) has announced that Chaudhary Zuraiz, Interim Chief Financial Officer and Vice President of Finance & Chief Accounting Officer, has made a purchase of 2,500 shares at a price of $3.5 per share on December 12, 2025.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios